|
gptkb:CAR-T_therapy
|
Phase III
|
|
gptkb:Leqembi
|
Phase 3
|
|
gptkb:KRT8_gene
|
immunohistochemistry for epithelial tumors
|
|
gptkb:SPT_621
|
Phase 3
|
|
gptkb:PLX4032
|
Phase III
|
|
gptkb:ALTU-238
|
Phase 1
|
|
gptkb:Sputnik_V
|
Phase III completed
|
|
gptkb:HeartMate_3
|
gptkb:MOMENTUM_3
|
|
gptkb:Fovista
|
Phase 3 (as of 2016)
|
|
gptkb:Rova-T
|
Phase III
|
|
gptkb:CAR-T_therapy
|
Phase II
|
|
gptkb:ALT-803
|
NCT02138734
|
|
gptkb:BROVCA1
|
genetic testing for cancer risk
|
|
gptkb:CYP21A2_gene
|
yes
|
|
gptkb:Immunic
|
multiple sclerosis
|
|
gptkb:tipifarnib
|
Phase III
|
|
gptkb:HER2-positive_breast_cancer
|
gptkb:APHINITY_trial
|
|
gptkb:entospletinib
|
Phase II
|
|
gptkb:ravidasvir/sofosbuvir
|
Phase III
|
|
gptkb:allogeneic_CAR-T_cells
|
investigational
|